Exane Derivatives Buys 14,046 Shares of Ingredion Incorporated (INGR)

Exane Derivatives boosted its stake in shares of Ingredion Incorporated (NYSE:INGR) by 468,200.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,049 shares of the company’s stock after purchasing an additional 14,046 shares during the period. Exane Derivatives’ holdings in Ingredion were worth $1,694,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of INGR. United Services Automobile Association lifted its position in shares of Ingredion by 3.3% in the first quarter. United Services Automobile Association now owns 24,371 shares of the company’s stock valued at $2,935,000 after buying an additional 770 shares during the last quarter. FMR LLC lifted its position in shares of Ingredion by 7.2% in the first quarter. FMR LLC now owns 260,682 shares of the company’s stock valued at $31,394,000 after buying an additional 17,595 shares during the last quarter. Global X Management Co. LLC lifted its position in shares of Ingredion by 30.0% in the first quarter. Global X Management Co. LLC now owns 1,325 shares of the company’s stock valued at $160,000 after buying an additional 306 shares during the last quarter. Menta Capital LLC lifted its position in shares of Ingredion by 25.7% in the first quarter. Menta Capital LLC now owns 4,820 shares of the company’s stock valued at $580,000 after buying an additional 986 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Ingredion by 7.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 3,995 shares of the company’s stock valued at $481,000 after buying an additional 270 shares during the last quarter. 83.87% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Exane Derivatives Buys 14,046 Shares of Ingredion Incorporated (INGR)” was published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.truebluetribune.com/2017/10/20/exane-derivatives-buys-14046-shares-of-ingredion-incorporated-ingr.html.

Shares of Ingredion Incorporated (NYSE INGR) traded up 0.67% during trading on Friday, hitting $123.98. The stock had a trading volume of 134,676 shares. The company has a market capitalization of $8.89 billion, a price-to-earnings ratio of 18.65 and a beta of 0.59. Ingredion Incorporated has a 52 week low of $113.07 and a 52 week high of $137.62. The company’s 50 day moving average price is $122.95 and its 200 day moving average price is $120.62.

Ingredion (NYSE:INGR) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $1.89 EPS for the quarter, beating the consensus estimate of $1.86 by $0.03. Ingredion had a return on equity of 20.84% and a net margin of 8.35%. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the prior year, the business earned $1.53 earnings per share. Ingredion’s revenue for the quarter was up .1% on a year-over-year basis. Analysts predict that Ingredion Incorporated will post $7.59 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Investors of record on Monday, October 2nd will be paid a $0.60 dividend. This is an increase from Ingredion’s previous quarterly dividend of $0.50. The ex-dividend date is Friday, September 29th. This represents a $2.40 annualized dividend and a yield of 1.94%. Ingredion’s dividend payout ratio is presently 36.09%.

INGR has been the subject of a number of recent analyst reports. Zacks Investment Research cut Ingredion from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. BidaskClub cut Ingredion from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 22nd. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $140.00.

In other Ingredion news, VP James P. Zallie sold 27,972 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $125.39, for a total transaction of $3,507,409.08. Following the sale, the vice president now owns 29,429 shares in the company, valued at $3,690,102.31. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP James P. Zallie sold 21,862 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $125.04, for a total value of $2,733,624.48. Following the sale, the vice president now owns 29,306 shares in the company, valued at approximately $3,664,422.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 52,882 shares of company stock worth $6,622,034. 1.92% of the stock is owned by company insiders.

About Ingredion

Ingredion Incorporated is an ingredients solutions provider. The Company manufactures and sells sweetener, starches, nutrition ingredients and biomaterial solutions derived from the wet milling and processing of corn and other starch-based materials to a range of industries, both domestically and internationally.

Institutional Ownership by Quarter for Ingredion (NYSE:INGR)

Receive News & Ratings for Ingredion Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply